Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Association of serum bilirubin levels with mortality in patients with diabetes initiating chronic hemodialysis: a competing risks analysis of a single-center cohort

Fig. 1

a Cumulative incidence of the all-cause mortality between the lower and higher bilirubin groups estimated using the cumulative incidence function (p = 0.054, Gray’s test). b Cumulative incidence of the atherosclerotic cardiovascular disease (ASCVD)-related mortality between the lower and higher bilirubin groups estimated using the cumulative incidence function (p = 0.005, Gray’s test). c Cumulative incidence of the non-ASCVD-related mortality between the lower and higher bilirubin groups estimated using the cumulative incidence function (p = 0.807, Gray’s test)

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us